Dr Philippe Dro
General Partner
BUSINESS MANAGEMENT
Aleva Neurotherapeutics
United States of America
Biography
Dr. Dro has 20 years of entrepreneurial experience in the life science industry, including a pivotal role in executing strategic transactions at several biotech and medtech companies. He has been CEO and a Member of the Supervisory Board of GlycoVaxyn AG since May 2008. Previously, Dr. Dro was CEO and Chairman of Endoart SA, a medtech company developing telemetry-driven implants for cardiac disease and obesity that was sold to Allergan, Inc. Dr. Dro received a doctorate in Pharmacy (Pharm D) from the School of Pharmacy of the University of Grenoble, France, and holds a joint MBA from Ecole Superieure de Commerce de Lyon, France, and Cranfield School of Management, United Kingdom. Dr. Dro has 20 years of entrepreneurial experience in the life science industry, including a pivotal role in executing strategic transactions at several biotech and medtech companies. He has been CEO and a Member of the Supervisory Board of GlycoVaxyn AG since May 2008. Previously, Dr. Dro was CEO and Chairman of Endoart SA, a medtech company developing telemetry-driven implants for cardiac disease and obesity that was sold to Allergan, Inc. Dr. Dro received a doctorate in Pharmacy (Pharm D) from the School of Pharmacy of the University of Grenoble, France, and holds a joint MBA from Ecole Superieure de Commerce de Lyon, France, and Cranfield School of Management, United Kingdom.
Research Interest
BUSINESS MANAGEMENT
